Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 19 studies | 46% ± 18% | |
epithelial cell | 13 studies | 37% ± 19% | |
type I pneumocyte | 12 studies | 39% ± 9% | |
astrocyte | 12 studies | 26% ± 10% | |
basal cell | 11 studies | 39% ± 17% | |
oligodendrocyte | 11 studies | 25% ± 7% | |
club cell | 10 studies | 28% ± 11% | |
goblet cell | 9 studies | 33% ± 12% | |
mesothelial cell | 9 studies | 35% ± 13% | |
adipocyte | 9 studies | 51% ± 11% | |
amacrine cell | 7 studies | 38% ± 16% | |
glutamatergic neuron | 6 studies | 37% ± 20% | |
type II pneumocyte | 6 studies | 24% ± 9% | |
retina horizontal cell | 6 studies | 28% ± 9% | |
respiratory goblet cell | 5 studies | 30% ± 9% | |
neuron | 5 studies | 31% ± 10% | |
brush cell | 5 studies | 22% ± 11% | |
hepatocyte | 5 studies | 41% ± 19% | |
deuterosomal cell | 4 studies | 24% ± 8% | |
ionocyte | 4 studies | 28% ± 7% | |
secretory cell | 4 studies | 29% ± 9% | |
abnormal cell | 4 studies | 27% ± 11% | |
enterocyte | 4 studies | 28% ± 5% | |
endothelial cell | 4 studies | 32% ± 15% | |
interneuron | 4 studies | 29% ± 13% | |
progenitor cell | 4 studies | 26% ± 8% | |
luminal hormone-sensing cell of mammary gland | 4 studies | 26% ± 9% | |
GABAergic neuron | 4 studies | 32% ± 17% | |
transit amplifying cell | 3 studies | 35% ± 24% | |
oligodendrocyte precursor cell | 3 studies | 23% ± 3% | |
retinal ganglion cell | 3 studies | 18% ± 2% | |
extravillous trophoblast | 3 studies | 68% ± 9% | |
squamous epithelial cell | 3 studies | 36% ± 20% | |
serous secreting cell | 3 studies | 23% ± 0% | |
glycinergic amacrine cell | 3 studies | 24% ± 7% | |
enteroendocrine cell | 3 studies | 32% ± 12% | |
luminal cell of prostate epithelium | 3 studies | 23% ± 7% | |
mucus secreting cell | 3 studies | 29% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 7811.32 | 180 / 180 | 99% | 203.05 | 427 / 430 |
esophagus | 100% | 17000.13 | 1441 / 1445 | 99% | 237.68 | 182 / 183 |
prostate | 100% | 17973.03 | 245 / 245 | 99% | 233.60 | 497 / 502 |
bladder | 100% | 13746.76 | 21 / 21 | 97% | 170.64 | 489 / 504 |
stomach | 100% | 11144.35 | 358 / 359 | 97% | 128.92 | 277 / 286 |
breast | 98% | 18855.77 | 448 / 459 | 99% | 246.87 | 1105 / 1118 |
intestine | 99% | 16965.64 | 960 / 966 | 97% | 133.28 | 511 / 527 |
uterus | 100% | 11779.45 | 170 / 170 | 96% | 186.90 | 440 / 459 |
pancreas | 99% | 10489.40 | 325 / 328 | 96% | 132.95 | 171 / 178 |
lung | 97% | 9008.04 | 558 / 578 | 98% | 190.05 | 1135 / 1155 |
thymus | 100% | 9104.63 | 652 / 653 | 93% | 138.44 | 565 / 605 |
liver | 100% | 17022.99 | 226 / 226 | 91% | 112.73 | 370 / 406 |
kidney | 100% | 7725.96 | 89 / 89 | 86% | 78.13 | 771 / 901 |
brain | 93% | 7002.35 | 2451 / 2642 | 83% | 60.12 | 587 / 705 |
skin | 96% | 22943.21 | 1740 / 1809 | 32% | 22.08 | 150 / 472 |
adrenal gland | 67% | 3110.68 | 173 / 258 | 35% | 17.42 | 81 / 230 |
tonsil | 0% | 0 | 0 / 0 | 100% | 256.54 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 66.47 | 1 / 1 |
adipose | 98% | 16913.35 | 1178 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 69% | 3333.61 | 919 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 19% | 7.33 | 15 / 80 |
heart | 10% | 397.69 | 83 / 861 | 0% | 0 | 0 / 0 |
spleen | 5% | 200.21 | 13 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 1.40 | 1 / 29 |
muscle | 2% | 102.00 | 19 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 3.58 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1900121 | Biological process | negative regulation of receptor binding |
GO_0099560 | Biological process | synaptic membrane adhesion |
GO_0007185 | Biological process | cell surface receptor protein tyrosine phosphatase signaling pathway |
GO_0035335 | Biological process | peptidyl-tyrosine dephosphorylation |
GO_0007155 | Biological process | cell adhesion |
GO_0031102 | Biological process | neuron projection regeneration |
GO_0016477 | Biological process | cell migration |
GO_0048679 | Biological process | regulation of axon regeneration |
GO_0070062 | Cellular component | extracellular exosome |
GO_0043025 | Cellular component | neuronal cell body |
GO_0005886 | Cellular component | plasma membrane |
GO_0043005 | Cellular component | neuron projection |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0050839 | Molecular function | cell adhesion molecule binding |
GO_0005001 | Molecular function | transmembrane receptor protein tyrosine phosphatase activity |
GO_0008201 | Molecular function | heparin binding |
GO_0035373 | Molecular function | chondroitin sulfate proteoglycan binding |
GO_0004725 | Molecular function | protein tyrosine phosphatase activity |
Gene name | PTPRF |
Protein name | Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR) Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) Protein tyrosine phosphatase receptor type F Receptor-type tyrosine-protein phosphatase F |
Synonyms | LAR |
Description | FUNCTION: Possible cell adhesion receptor. It possesses an intrinsic protein tyrosine phosphatase activity (PTPase) and dephosphorylates EPHA2 regulating its activity.; FUNCTION: The first PTPase domain has enzymatic activity, while the second one seems to affect the substrate specificity of the first one. |
Accessions | H0Y380 P10586 ENST00000414879.5 ENST00000412568.6 H0Y4H1 H0Y7Z9 ENST00000429895.5 ENST00000438120.5 [P10586-2] H0Y6Z7 ENST00000617451.4 G1UI20 A2A437 ENST00000359947.9 [P10586-1] ENST00000372407.4 ENST00000437607.1 |